Abstract
Recent evidence suggests that a group of psoriasis patients have silent gluten intolerance and may experience improvement of their psoriasis by going on a gluten-free diet. Although there is still controversy as to the prevalence of this subset of psoriasis patients, screening patients with moderate to severe psoriasis for antigliadin antibodies may be helpful in identifying this group. Evidence illustrates that patients with positive antigliadin antibodies who undertake a gluten-free diet experience significant improvement of their psoriasis compared with prediet measurements. To make definitive clinical recommendations, a large randomized, controlled trial is needed. Even though the evidence is limited, it may be beneficial to screen psoriasis patients for silent gluten intolerance to identify those who could benefit from a gluten-free diet.
Get full access to this article
View all access options for this article.
